Novartis AG
ANTIVIRAL 1,3-DI-OXO-INDENE COMPOUNDS
Last updated:
Abstract:
This disclosure provides compounds of Formula (I) ##STR00001## as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salts and compositions for treating viral infections.
Status:
Application
Type:
Utility
Filling date:
20 Apr 2021
Issue date:
21 Oct 2021